Marcel Scheepstra
Director, Organic chemistry, Bioconjugates R&D Lonza Advanced Synthesis
Seminars
Thursday 11th June 2026
Lonza’s End-to-End Offering for Best-in-Class Targeted Therapies Based on GlycoConnect® & HydraSpace® Technologies
8:30 am
- Exploring how GlycoConnect® and HydraSpace® technologies enable ADCs with best-in-class therapeutic potential
- Sharing clinical development insights on the rapidly advancing pipeline of GlycoConnect® ADCs by partners
- GlycoConnect® technology expansion for dual-payload ADCs with compelling in vivo data
